New Alzheimer's drug shows promise in early trial
NCT ID NCT05811442
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new drug called 50561 in 68 people with mild to moderate Alzheimer's disease. Participants received either a high dose, low dose, or a placebo. The main goal was to see if the drug could slow down cognitive decline over 24 weeks using a standard memory and thinking test.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
50561
What this could lead to
If successful, this could point toward a new treatment to slow cognitive decline in Alzheimer's disease.
What could go wrong
This is an early Phase IIa trial with only 68 participants, so results may not be conclusive. The drug may not show meaningful benefit over placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anding Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Heilongjiang Provincial Hospital of Traditional Chinese Medicine
Haerbin, Heilongjiang, China
-
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
-
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
-
The First affiliated hospital of SOOCHOW university
Suzhou, Jiangsu, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
-
Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, China
-
Wuhan Union Hospital of China
Wuhan, Hubei, China
-
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, 100053, China